Uni-Bio Science develops and commercialises innovative biopharmaceuticals. Since 2001, we have been bringing high quality science and treatments to patients in China. Our highly differentiated products are focused on the treatment of chronic conditions in diabetes, ophthalmology and dermatology, demonstrating clear clinical advantages over currently available treatments.
Uni-Bio Science has a strong and diverse sales and marketing footprint in the key cities of China and is actively broadening its reach in the large and growing Chinese healthcare market to the benefit of the Company and its partners.
The Group's commercial team leverages decades of sales and marketing experience in Asia from international pharmaceutical companies, is highly experienced in new product launches in China and developing market access strategies. The fast-growing team devises and employs highly-compliant, innovative commercialisation strategies for an increasing portfolio of products.